Insights On Drug Development
-
From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined
10/14/2025
Explore examples of smarter SAD/MAD trial designs including multi-part and hybrid protocols, regulatory foresight, recruitment considerations, and operational strategies that keep programs moving.
-
Top 8 Considerations For Choosing A PDX Model
10/7/2025
To guide your decision-making, we’ve outlined the top 10 criteria to consider when evaluating PDX models for your next oncology research or drug development program.
-
Sniffing Out Solutions In The Nasal Drug Delivery Revolution
10/7/2025
As research continues to advance, nasal drug delivery stands at the intersection of innovation and practicality — offering a unique opportunity to expand therapeutic reach while rethinking how medicines are administered and experienced.
-
Human iPSC Modeling, Drug Screening For Neurodegenerative Disorders
10/3/2025
iPSC technology enables genetically engineered human cells for neurotoxicity and neuroprotection assays, offering scalable disease models for drug discovery and toxicity screening.
-
What Are The Keys To Making Rare Disease Drug Development Sustainable?
9/30/2025
This roundtable weaves together diverse perspectives, providing a multifaceted look at what it will take to create a sustainable path forward in rare disease drug development.
-
Utilizing Flow Cytometry For Humoral Immunogenicity Testing: Cell & Gene Therapy
9/29/2025
Discover strategies to overcome immunogenicity challenges in cell and gene therapies, with a focus on harnessing flow cytometry to enhance ADA and NAb assay development, strengthen validation, and ensure regulatory readiness.
-
Streamlining Biologics Development: Leveraging Small-Scale Studies For Greater Efficiency
9/25/2025
Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities.
-
Overcoming Unique Client Challenges With A Strong Collaborative Partnership
9/23/2025
Through close collaboration, proactive communication, and agile project management, our partnership accelerated an oncology program and helped overcome complex preclinical hurdles.
-
Advancing ADC Development: Overcoming Preclinical Challenges
9/23/2025
Learn how to accelerate the journey of ADC candidates from early discovery to clinical development, enhancing the success rate of translating preclinical discoveries into effective cancer treatments.
-
BxPC-3: Evaluating Responses To Standard Therapeutic Agents
9/23/2025
Review multiple studies utilizing the BxPC-3 human pancreatic cancer model in subcutaneous (SC) NSG and NSG-dKO mouse models, evaluating a range of standard agents, vehicles, and delivery methods.